234 related articles for article (PubMed ID: 25074533)
1. Therapeutic strategy for ductal carcinoma in situ patients according to Van Nuys Prognostic Index.
Andretta M; Scomersi S; Urbani M; Bortul M
Ann Ital Chir; 2014; 85(3):254-9. PubMed ID: 25074533
[TBL] [Abstract][Full Text] [Related]
2. Management of ductal carcinoma in situ according to Van Nuys Prognostic Index in Australia and New Zealand.
Whitfield R; Kollias J; de Silva P; Turner J; Maddern G
ANZ J Surg; 2012; 82(7-8):518-23. PubMed ID: 22758922
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.
Kuo SH; Lo C; Chen YH; Lien HC; Kuo WH; Wang MY; Lee YH; Huang CS
Clin Breast Cancer; 2018 Dec; 18(6):441-450.e2. PubMed ID: 29709458
[TBL] [Abstract][Full Text] [Related]
4. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
5. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
[TBL] [Abstract][Full Text] [Related]
6. Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations.
de Mascarel I; Bonichon F; MacGrogan G; de Lara CT; Avril A; Picot V; Durand M; Mauriac L; Trojani M; Coindre JM
Breast Cancer Res Treat; 2000 May; 61(2):151-9. PubMed ID: 10942101
[TBL] [Abstract][Full Text] [Related]
7. An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ.
MacAusland SG; Hepel JT; Chong FK; Galper SL; Gass JS; Ruthazer R; Wazer DE
Cancer; 2007 Dec; 110(12):2648-53. PubMed ID: 17960606
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
[TBL] [Abstract][Full Text] [Related]
9. Ductal carcinoma in situ--the influence of the radiotherapy boost on local control.
Wong P; Lambert C; Agnihotram RV; David M; Duclos M; Freeman CR
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e153-8. PubMed ID: 21664063
[TBL] [Abstract][Full Text] [Related]
10. The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ.
Gilleard O; Goodman A; Cooper M; Davies M; Dunn J
World J Surg Oncol; 2008 Jun; 6():61. PubMed ID: 18564426
[TBL] [Abstract][Full Text] [Related]
11. Fine tuning of the Van Nuys prognostic index (VNPI) 2003 by integrating the genomic grade index (GGI): new tools for ductal carcinoma in situ (DCIS).
Altintas S; Toussaint J; Durbecq V; Lambein K; Huizing MT; Larsimont D; Van Marck E; Vermorken JB; Tjalma WA; Sotiriou C
Breast J; 2011; 17(4):343-51. PubMed ID: 21645166
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of predictive factors, particularly the Van Nuys index, of local recurrence in ductal carcinoma in situ of the breast: study of 166 cases with conservative treatment and review of the literature].
Denoux Y; Marnay J; Crouet H; Boute V; Delozier T; Vie B; Chasle J
Bull Cancer; 2001 Apr; 88(4):419-25. PubMed ID: 11371378
[TBL] [Abstract][Full Text] [Related]
13. The value of the Van Nuys Prognostic Index in ductal carcinoma in situ of the breast: a retrospective analysis.
Asjoe FT; Altintas S; Huizing MT; Colpaert C; Marck EV; Vermorken JB; Tjalma WA
Breast J; 2007; 13(4):359-67. PubMed ID: 17593040
[TBL] [Abstract][Full Text] [Related]
14. A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma
Mittal K; Toss MS; Wei G; Kaur J; Choi DH; Melton BD; Osan RM; Miligy IM; Green AR; Janssen EAM; Søiland H; Gogineni K; Manne U; Rida P; Rakha EA; Aneja R
Clin Cancer Res; 2020 Jun; 26(12):2898-2907. PubMed ID: 31937618
[TBL] [Abstract][Full Text] [Related]
15. Analyzing the risk of recurrence after mastectomy for DCIS: a new use for the USC/Van Nuys Prognostic Index.
Kelley L; Silverstein M; Guerra L
Ann Surg Oncol; 2011 Feb; 18(2):459-62. PubMed ID: 20859695
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinoma in situ: a disease entity that merits more recognition.
Dereere E; Papadimitriou K; Tjalma W; Altintas S
Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
[TBL] [Abstract][Full Text] [Related]
17. The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast.
Silverstein MJ
Am J Surg; 2003 Oct; 186(4):337-43. PubMed ID: 14553846
[TBL] [Abstract][Full Text] [Related]
18. Treatment selection for patients with ductal carcinoma in situ (DCIS) of the breast using the University of Southern California/Van Nuys (USC/VNPI) prognostic index.
Silverstein MJ; Lagios MD
Breast J; 2015; 21(2):127-32. PubMed ID: 25600630
[TBL] [Abstract][Full Text] [Related]
19. Contemporary treatment of ductal carcinoma in situ of the breast.
Mokbel K
Med Sci Monit; 2005 Mar; 11(3):RA86-93. PubMed ID: 15735580
[TBL] [Abstract][Full Text] [Related]
20. Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.
Cutuli B; De Lafontan B; Kirova Y; Auvray H; Tallet A; Avigdor S; Brunaud C; Delva C
Radiat Oncol; 2015 May; 10():110. PubMed ID: 25944033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
